LUNG Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -0.09% compare to its pairs and should correct downwards.

Stats
Dzisiejszy wolumen	575 992
Średni wolumen	473 011
Kapitalizacja rynkowa	246.09M
EPS	$-0.360 ( Q1 \| 2024-05-03 )
Następna data zysków	( $-0.410 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.12 (Sector) 42.63 (Industry) 0
ATR14	$0.0110 (0.17%)

AEMD -13.81%

AFIB -13.41%

AHCO 1.42%

AHPI 0.00%

ALGN -0.65%

ANIK -1.52%

APEN 0.00%

APYX -4.96%

ARAY 1.68%

ATEC 0.58%

AXDX 1.74%

AXGN 0.28%

AXNX -0.25%

AZYO 2.05%

BBLG 0.83%

BIOL 38.50%

BJDX -6.77%

BMRA -2.16%

BRKR -0.61%

BSGM -5.35%

BWAY 0.83%

CERS 0.57%

CFMS 0.44%

CLPT -5.11%

CODX -1.57%

CSII 0.15%

CTKB 1.64%

CTSO -9.00%

CUTR 3.42%

CVRX 2.48%

DCTH 1.70%

DXCM -1.01%

DYNT -20.97%

EAR -4.10%

ECOR -0.16%

EDAP 4.21%

ESTA 3.56%

FONR 1.46%

HJLI -1.98%

HSDT -1.99%

HSKA 0.00%

HYPR -11.00%

IART 1.36%

ICAD 0.00%

ICCM -1.99%

IINN -2.13%

INGN 2.01%

INMD 1.00%

IRIX 0.00%

IRMD -0.05%

IRTC 3.12%

ISO 0.00%

ITMR 0.00%

KIDS -0.10%

LHDX 0.00%

LIVN -0.02%

LNSR 2.74%

LUCD -5.64%

LUNG 2.76%

MASS 0.00%

MDGS 10.28%

MOTS 0.17%

MOVE -3.51%

MSON 0.00%

NAOV -5.41%

NARI 2.47%

NMRD 0.00%

NNOX 10.71%

NPCE 8.00%

NTUS 0.00%

NURO 0.27%

NUVA -2.24%

NUWE 18.57%

NVCN 0.00%

NVNO 1.55%

OBLN -5.86%

OFIX -1.63%

OM -7.00%

PACB 0.74%

PAVM 6.30%

PETV 0.00%

PODD -2.50%

PRCT 2.28%

PROF -4.88%

QIPT 3.54%

QTRX 1.62%

RCEL -0.38%

RPID -4.90%

RSLS -3.23%

RWLK 6.07%

RXST 1.81%

SGHT 1.99%

SIBN 4.02%

SIEN -18.69%

SILK 0.52%

SINT -6.98%

SOLY 0.00%

SRDX 0.17%

SRGA 0.00%

SRTS 1.72%

SWAV 0.00%

TBIO -8.29%

TCMD 3.20%

TELA -8.56%

THMO 9.52%

TIVC -1.02%

TLIS 0.72%

TMCI 0.15%

TMDI 0.00%

TMDX 1.89%

TNDM -0.35%

TNON 0.00%

UFPT 2.41%

VERO -2.71%

VIVE 0.00%

VMD 1.24%

VRAY 0.00%

VREX 0.75%

VVOS -7.11%

XAIR -7.38%

XENT 0.00%

ZIMV 3.75%

Insider Trading

Date	Person	Action	Amount	type
2024-06-24	Rose Geoffrey Beran	Sell	1 184	Common Stock
2024-06-03	Burns Thomas William	Buy	15 216	Common Stock
2024-06-03	Ferrari Richard	Buy	15 216	Common Stock
2024-06-03	Florin Daniel P	Buy	15 216	Common Stock
2024-06-03	Sullivan Tiffany	Buy	15 216	Common Stock

INSIDER POWER
80.45
Last 98 transactions
Buy: 1 650 086 \| Sell: 224 349

Korelacja (AI algo v.1.1b): Overvalued: -0.09% $6.35 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: 0.59 (weak)

Krótki: -0.14 (neutral)

Signal:(68.307) Neutral

Pulmonx Corporation Korelacja

10 Najbardziej pozytywne korelacje
DBX	0.957
ROKU	0.932
RAPT	0.93
MFIN	0.928
GASS	0.916
SSP	0.913
QDEL	0.912
SMSI	0.91
UDMY	0.91
AKAM	0.907

10 Najbardziej negatywne korelacje
VNOM	-0.934
HOOD	-0.932
FANG	-0.925
SANG	-0.921
DTSS	-0.919
IINN	-0.919
NRIX	-0.916
KELYA	-0.903
ACVA	-0.9
COIN	-0.9

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pulmonx Corporation Korelacja - Waluta/Towar

-0.24
( neutral )

-0.04
( neutral )

0.00
( neutral )

-0.26
( neutral )

0.00
( neutral )

0.33
( neutral )

Pulmonx Corporation Finanse

Annual	2023
Przychody:	$68.68M
Zysk brutto:	$50.35M (73.32 %)
EPS:	$-1.600

FY	2023
Przychody:	$68.68M
Zysk brutto:	$50.35M (73.32 %)
EPS:	$-1.600

FY	2022
Przychody:	$53.66M
Zysk brutto:	$39.87M (74.29 %)
EPS:	$-1.590

FY	2021
Przychody:	$48.42M
Zysk brutto:	$35.63M (73.59 %)
EPS:	$-1.350

Financial Reports:

No articles found.

Pulmonx Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.